Basic Science and Pathogenesis.

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Alzheimer's disease (AD) pathogenesis involves oxidative stress and inflammation.
• Plant-based compounds with antioxidant properties, like Lutein-20, require evaluation in AD models.
• Assessing antioxidant and inflammatory markers, plus histological changes, is crucial for understanding therapeutic potential.

Purpose of the Study:

• To evaluate the ethnopharmacology of Lutein-20 in an animal model of Alzheimer's disease.
• To assess the effects of Lutein-20 on antioxidant and inflammatory indexes in the prefrontal cortex and hippocampus.
• To investigate the histological changes in brain regions affected by AD.

Main Methods:

• Wistar rats were divided into control, Lutein-20 treated, AD model (cadmium-induced), and AD model with Lutein-20 treatment groups.
• Serum analysis included malondialdehyde (MDA), total protein, tumor necrosis factor alpha (TNF-α), superoxide dismutase (SOD), and catalase (CAT).
• Statistical analysis was performed using one-way ANOVA (p < 0.05).

Main Results:

• Cadmium exposure significantly increased oxidative stress (MDA) and pro-inflammatory cytokines (TNF-α) while decreasing antioxidant enzymes (SOD, CAT, GSH).
• Lutein-20 administration significantly reduced oxidative damage and suppressed neuroinflammation.
• Lutein-20 treatment elevated antioxidant enzyme activities and mitigated neurodegeneration in the prefrontal cortex and hippocampus.

Conclusions:

• Lutein-20 attenuates pro-inflammatory cytokines and enhances antioxidant enzyme activity.
• These findings highlight Lutein-20's neuroprotective potential as a therapeutic agent for neurodegenerative conditions.
• Further research into Lutein-20's mechanism of action in AD is warranted.